Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients

The InSite trial is a prospective, multicenter post‐approval study of subjects receiving sacral neuromodulation (SNM) therapy with the InterStim® System. Enrolled subjects had bothersome symptoms of overactive bladder (OAB). The purpose of this analysis was to determine if severity of baseline symptoms had an impact on clinical outcomes.

[1]  K. Kreder,et al.  Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients , 2017, Neurourology and urodynamics.

[2]  H. Zyczynski,et al.  OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. , 2016, JAMA.

[3]  C. Comiter,et al.  Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation. , 2016, Urology.

[4]  C. Comiter,et al.  Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder , 2016, Neurourology and urodynamics.

[5]  M. Faraday,et al.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. , 2015, The Journal of urology.

[6]  C. Comiter,et al.  Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder , 2015, Neurourology and urodynamics.

[7]  C. Spino,et al.  Anticholinergic therapy vs. OnabotulinumtoxinA for urgency urinary incontinence , 2013 .

[8]  C. Spino,et al.  Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. , 2012, The New England journal of medicine.

[9]  L. Matza,et al.  Determining the importance of change in the overactive bladder questionnaire. , 2006, The Journal of urology.

[10]  G. Webster,et al.  Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? , 2005, Urology.

[11]  D. Revicki,et al.  Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q , 2002, Quality of Life Research.

[12]  M. Elhilali,et al.  Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. , 2000, The Journal of urology.

[13]  Richard A. Schmidt,et al.  SACRAL NERVE STIMULATION FOR TREATMENT OF REFRACTORY URINARY URGE INCONTINENCE , 1999 .